Search This Blog

Thursday, February 27, 2020

NeoGenomics EPS beats by $0.04, beats on revenue

NeoGenomics (NASDAQ:NEO): Q4 Non-GAAP EPS of $0.10 beats by $0.04; GAAP EPS of $0.06 beats by $0.04.
Revenue of $106.87M (+39.7% Y/Y) beats by $2.62M.
Press Release
https://seekingalpha.com/news/3546384-neogenomics-eps-beats-0_04-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)